Regulation of FasL by NF-κB and AP-1 in Fas-dependent thymineless death of human colon carcinoma cells

被引:67
作者
Harwood, FG
Kasibhatla, S
Petak, I
Vernes, R
Green, DR
Houghton, JA
机构
[1] St Jude Childrens Res Hosp, Dept Mol Pharmacol, Memphis, TN 38105 USA
[2] Cytovia Inc, San Diego, CA 92121 USA
[3] La Jolla Inst Allergy & Immunol, Dept Cellular Immunol, San Diego, CA 92121 USA
关键词
D O I
10.1074/jbc.275.14.10023
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cell death due to thymine (dThd) deficiency, associated with the cytotoxic action of 5-fluorouracil in colon cancer, is regulated in thymidylate synthase-deficient (TS-) human colon carcinoma cells via the Fas (CD95, APO-1) death receptor. This was demonstrated by inhibiting the loss in clonogenicity of TS- cells by anti-Fast and in enhanced survival of TS- clones selected for resistance to Fas-mediated apoptosis, following dThd deprivation, During thymineless stress in TS- cells, Fas ligand (FasL) is expressed, and its promoter (hFasLPr) is activated. Transactivation of hFasLPr, dependent upon dThd deficiency, was inhibited following mutation of the binding sites for NF-kappa B or AP-1 and by preventing NF-kappa B or AP-1 activation, which inhibited expression of Fast and enhanced clonogenic survival in stable transformants expressing I kappa B alpha M Or DN-MEKK, respectively. These results demonstrate the crucial roles for NF-kappa B and AP-1 in the regulation of Fast in Fas-mediated thymineless death of colon carcinoma cells.
引用
收藏
页码:10023 / 10029
页数:7
相关论文
共 28 条
[1]   PYRROLIDINE DITHIOCARBAMATE, A POTENT INHIBITOR OF NUCLEAR FACTOR KAPPA-B (NF-KAPPA-B) ACTIVATION, PREVENTS APOPTOSIS IN HUMAN PROMYELOCYTIC LEUKEMIA HL-60 CELLS AND THYMOCYTES [J].
BESSHO, R ;
MATSUBARA, K ;
KUBOTA, M ;
KUWAKADO, K ;
HIROTA, H ;
WAKAZONO, Y ;
LIN, YW ;
OKUDA, A ;
KAWAI, M ;
NISHIKOMORI, R ;
HEIKE, T .
BIOCHEMICAL PHARMACOLOGY, 1994, 48 (10) :1883-1889
[2]   Daunorubicin activates NF kappa B and induces kappa B-dependent gene expression in HL-60 promyelocytic and Jurkat T lymphoma cells [J].
Boland, MP ;
Foster, SJ ;
ONeill, LAJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (20) :12952-12960
[3]  
BRACH MA, 1992, BLOOD, V79, P728
[4]  
BRACH MA, 1992, MOL PHARMACOL, V41, P60
[5]   AUTOCRINE T-CELL SUICIDE MEDIATED BY APO-1/(FAS/CD95) [J].
DHEIN, J ;
WALCZAK, H ;
BAUMLER, C ;
DEBATIN, KM ;
KRAMMER, PH .
NATURE, 1995, 373 (6513) :438-441
[6]  
Faris M, 1998, J IMMUNOL, V160, P134
[7]   Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells [J].
Friesen, C ;
Herr, I ;
Krammer, PH ;
Debatin, KM .
NATURE MEDICINE, 1996, 2 (05) :574-577
[8]  
Harwood FG, 1996, ONCOGENE, V12, P2057
[9]   Nuclear factor -: κB-dependent regulation of p53 gene expression induced by daunomycin genotoxic drug [J].
Hellin, AC ;
Calmant, P ;
Gielen, J ;
Bours, V ;
Merville, MP .
ONCOGENE, 1998, 16 (09) :1187-1195
[10]   Thymineless death in colon carcinoma cells is mediated via Fas signaling [J].
Houghton, JA ;
Harwood, FG ;
Tillman, DM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (15) :8144-8149